Hepatitis Research

In cooperation with the National Institutes of Health (NIH), the Mongolian Academy of Medical Sciences and the Mongolian Ministry of Health, FIRE has initiated an effort to study the prevalence of blood borne viruses among 1,000 urban, suburban and rural health care workers in Mongolia.  NIH will scientifically study the relationship between Mongolians and Hepatitis B, C and D using cutting-edge technology to provide heretofore-unavailable information to the Mongolian health sector for the treatment and prevention of viruses, specifically hepatitis.  The study’s results will provide deep insight into transmittable infections (i.e. is there a genetic predisposition toward contracting hepatitis, or against being able to clear it?).


This study will provide Mongolian authorities with a highly specific resource from which to form health policy and develop strategies for increasing awareness, prevention, detection and treatment of health care workers.  This study has gained the professional expertise and support of leading hepatitis researchers from within NIH, such as Dr. Harvey Alter, who co-discovered the hepatitis B vaccine and led the research team that identified hepatitis C, and Dr. Stefano Bertuzzi, one of the top administrators in the Office of the Director at NIH and adviser to the US President.  Dr. Samuel So, a Liver Cancer Surgeon who teaches at Stanford University the President of the Asian Liver Foundation, and a special adviser to WHO on viral hepatitis is also an adviser for this program.


Currently, FIRE has finished the collection of samples. NIH is currently in the process of testing all samples.  FIRE is process the risk factor questionnaire and beginning to work on data correlation


Long-term, it is hoped that the data created by this project will help secure funding for vaccination, education and prevention programs in Mongolia.


FIRE is a registered 501c.3 non-profit organization. All donations are tax deductible.